{"id":"W2946837939","doi":"10.1200/jco.2019.37.15_suppl.5029","title":"Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort B of the phase 1b/2 KEYNOTE-365 study.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Docetaxel; Abiraterone; Enzalutamide; Prednisone; Prostate cancer; Internal medicine; Cancer; Cohort; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009560902,0.0007020934,0.0008748774,0.0002406211,0.000277992,0.0005774738,0.000408376,0.000543949,0.002251999],"category_scores_gemma":[0.0004227347,0.0004403086,0.0006542291,0.0003830474,0.0003268363,0.0005622279,0.0002910075,0.00158513,0.0005803824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007723082,"about_ca_system_score_gemma":0.001003548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001755894,"about_ca_topic_score_gemma":0.005898253,"domain_scores_codex":[0.9997771,0.00009428767,0.00002015169,0.00003985289,0.00002656457,0.00004195253],"domain_scores_gemma":[0.9997193,0.00002748061,0.00005985815,0.00001590404,0.00001204307,0.000165446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7270927,0.04898418,0.04502125,0.001359692,0.002640389,0.0004912504,0.0005004889,0.002521513,0.03886668,0.0002243106,0.007222343,0.1250751],"study_design_scores_gemma":[0.4592377,0.4224692,0.1022685,0.0001443844,0.00150852,0.0007548711,0.0001710604,0.001235202,0.003558129,0.0001903491,0.008425899,0.0000360435],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946811,0.002167239,0.000176385,0.0002045305,0.00003931577,0.0008041451,0.0008497123,0.00002248346,0.001054913],"genre_scores_gemma":[0.9946626,0.00155052,0.0004558572,0.0003687961,0.00006964189,0.000432623,0.001266333,0.00000640084,0.001187292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002251999,"threshold_uncertainty_score":0.007533729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08929796729595767,"score_gpt":0.4626246529269634,"score_spread":0.3733266856310057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}